These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16678652

  • 1. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis.
    Kalsekar ID, Madhavan SS, Amonkar MM, Douglas SM, Makela E, Elswick BL, Scott V.
    Clin Ther; 2006 Feb; 28(2):306-18. PubMed ID: 16678652
    [Abstract] [Full Text] [Related]

  • 2. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
    Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL.
    Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
    [Abstract] [Full Text] [Related]

  • 3. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
    Kalsekar I, Sheehan C, Peak A.
    Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
    [Abstract] [Full Text] [Related]

  • 4. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP, Unger AN, Lustik MB.
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [Abstract] [Full Text] [Related]

  • 5. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [Abstract] [Full Text] [Related]

  • 6. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [Abstract] [Full Text] [Related]

  • 7. Antidiabetic therapy before and 1 year after discharge for patients manifesting in-hospital hyperglycemia.
    Waddell M, Flanders SJ, Golas A, Zhang Q, Juneja R.
    Postgrad Med; 2009 May; 121(3):61-6. PubMed ID: 19491541
    [Abstract] [Full Text] [Related]

  • 8. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 9. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C, Barner JC, Lawson KA, Johnsrud MT.
    Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
    [Abstract] [Full Text] [Related]

  • 10. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB, Dy SM, Millman EA, Herbert R, Bass EB, Wu A.
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [Abstract] [Full Text] [Related]

  • 11. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
    Mody R, Kalsekar I, Kavookjian J, Iyer S, Rajagopalan R, Pawar V.
    J Diabetes Complications; 2007 Aug; 21(2):75-83. PubMed ID: 17331855
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of depression on health care utilization and costs in patients with type 2 diabetes.
    Kalsekar ID, Madhavan SM, Amonkar MM, Scott V, Douglas SM, Makela E.
    Manag Care Interface; 2006 Mar; 19(3):39-46. PubMed ID: 16583789
    [Abstract] [Full Text] [Related]

  • 14. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O, Wade R, Gu T, Bouchard JR, Aagren M, Luo W.
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [Abstract] [Full Text] [Related]

  • 15. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
    Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH.
    Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
    [Abstract] [Full Text] [Related]

  • 16. Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record.
    Brouwer ES, West SL, Kluckman M, Wallace D, Masica AL, Ewen E, Kudyakov R, Cheng D, Bowen J, Fleming NS.
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):920-8. PubMed ID: 22250059
    [Abstract] [Full Text] [Related]

  • 17. Using a pharmaco-epidemiological approach to estimate diabetes type 2 prevalence in Portugal.
    Duarte-Ramos F, Cabrita J.
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):269-74. PubMed ID: 16294365
    [Abstract] [Full Text] [Related]

  • 18. Type 2 diabetes does not increase risk of depression.
    Brown LC, Majumdar SR, Newman SC, Johnson JA.
    CMAJ; 2006 Jul 04; 175(1):42-6. PubMed ID: 16818907
    [Abstract] [Full Text] [Related]

  • 19. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L, Zhao Y, Foster TS, Fraser K, Bledsoe SL, Russell MW.
    Curr Med Res Opin; 2009 Jul 04; 25(7):1763-73. PubMed ID: 19505204
    [Abstract] [Full Text] [Related]

  • 20. Oral hypoglycemics: increased postoperative mortality in coronary risk patients.
    Jeger RV, Seeberger MD, Keller U, Pfisterer ME, Filipovic M.
    Cardiology; 2007 Jul 04; 107(4):296-301. PubMed ID: 17264509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.